BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fulda S. Targeting apoptosis signaling pathways for anticancer therapy. Front Oncol 2011;1:23. [PMID: 22655234 DOI: 10.3389/fonc.2011.00023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Liu H, Wu X, Shi C, Li W, Yuan Y, Liu Y, Xing D. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway. J Biol Inorg Chem 2022. [PMID: 35817878 DOI: 10.1007/s00775-022-01943-6] [Reference Citation Analysis]
2 Skrajnowska D, Jagielska A, Ruszczyńska A, Idkowiak J, Bobrowska-korczak B. Effect of Copper and Selenium Supplementation on the Level of Elements in Rats’ Femurs under Neoplastic Conditions. Nutrients 2022;14:1285. [DOI: 10.3390/nu14061285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Djordjoliani P, Bokhua Z, Burkadze G. Features of the endometrial microenvironment in developing of endometrioid adenocarcinoma. gs 2022. [DOI: 10.52340/gs.2022.04.02.03] [Reference Citation Analysis]
4 Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, Mei C, Jiang X, Chen Y, Wang G, Wang K, Liu Y, Guo Y, Liu Z, Yuan Y. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis 2021;12:425. [PMID: 33931585 DOI: 10.1038/s41419-021-03711-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
5 Chmurska A, Matczak K, Marczak A. Two Faces of Autophagy in the Struggle against Cancer. Int J Mol Sci 2021;22:2981. [PMID: 33804163 DOI: 10.3390/ijms22062981] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
6 Li K. Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology. Bioorganic & Medicinal Chemistry Letters 2021;32:127717. [DOI: 10.1016/j.bmcl.2020.127717] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Periasamy VS, Riyasdeen A, Rajendiran V, Palaniandavar M, Krishnamurthy H, Alshatwi AA, Akbarsha MA. Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study. Molecules 2020;25:E4504. [PMID: 33019623 DOI: 10.3390/molecules25194504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lu X, Liu YC, Orvig C, Liang H, Chen ZF. Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent. J Med Chem 2020;63:9154-67. [PMID: 32794745 DOI: 10.1021/acs.jmedchem.9b02047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
9 Messeha SS, Zarmouh NO, Asiri A, Soliman KFA. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol 2020;885:173419. [PMID: 32750370 DOI: 10.1016/j.ejphar.2020.173419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
10 Akhtar N, Biswas O, Manna D. Biological applications of synthetic anion transporters. Chem Commun 2020;56:14137-53. [DOI: 10.1039/d0cc05489e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
11 Lu X, Liu Y, Orvig C, Liang H, Chen Z. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models. European Journal of Medicinal Chemistry 2019;181:111567. [DOI: 10.1016/j.ejmech.2019.111567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
12 Zhao H, Yan L, Xu X, Jiang C, Shi J, Zhang Y, Liu L, Lei S, Shao D, Huang Q. Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells. AMB Express 2018;8:78. [PMID: 29777449 DOI: 10.1186/s13568-018-0606-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
13 Zhang S, Cao L, Wang Z, Li Z, Ma J. Anti-cancer effect of toosendanin and its underlying mechanisms. Journal of Asian Natural Products Research 2019;21:270-83. [DOI: 10.1080/10286020.2018.1451516] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
14 Nhu D, Lessene G, Huang DCS, Burns CJ. Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy. Med Chem Commun 2016;7:778-87. [DOI: 10.1039/c5md00582e] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
15 Jakimov DS, Kojić VV, Aleksić LD, Bogdanović GM, Ajduković JJ, Djurendić EA, Penov Gaši KM, Sakač MN, Jovanović-šanta SS. Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells. Bioorganic & Medicinal Chemistry 2015;23:7189-98. [DOI: 10.1016/j.bmc.2015.10.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
16 Xiong T, Chen X, Wei H, Xiao H. Influence of PJ34 on the genotoxicity induced by melphalan in human multiple myeloma cells. Arch Med Sci 2015;11:301-6. [PMID: 25995744 DOI: 10.5114/aoms.2014.43164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
17 Zhang MJ, Liu SN, Xu G, Guo YN, Fu JN, Zhang DC. Cytotoxicity and apoptosis induced by nanobacteria in human breast cancer cells. Int J Nanomedicine 2014;9:265-71. [PMID: 24403832 DOI: 10.2147/IJN.S54906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
18 Grandhi BK, Thakkar A, Wang J, Prabhu S. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res (Phila) 2013;6:1015-25. [PMID: 24072676 DOI: 10.1158/1940-6207.CAPR-13-0172] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
19 Węsierska-Gądek J, Zulehner N, Ferk F, Składanowski A, Komina O, Maurer M. PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells. Biochem Pharmacol 2012;84:1318-31. [PMID: 22906755 DOI: 10.1016/j.bcp.2012.07.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]